Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JATENZO in Hypogonadal Men With Chronic Kidney Disease
NCT05249634Phase 2Recruiting
- Sponsor
- Saint Louis University
- Start
- Mar 2022
- Primary completion
- Jun 2028
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testosterone undecanoate in Hypogonadism, sponsored by Saint Louis University. Primary endpoint: Testosterone concentrations at 6 months. Started Mar 2022; status: recruiting.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT05249634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249634.